Print Page   |   Contact Us   |   Sign In   |   Join
Vericel Corporation
Profile Pages More
Photo Not Available
Last updated: Yesterday
Vericel Corporation
Bioscience Company
Organization Information
Vericel Corporation
24 Frank Lloyd Wright Drive
Ann Arbor
48105  United States
 [ Map ]
Visit Website »
  Founded in 1989, Vericel (formerly Aastrom Biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-T, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM).
  Pharma & Therapeutics - Regenerative Medicine
  Pharma & Therapeutics - Regenerative Medicine, Pharma & Therapeutics - Rx & Consumer Health
  Cardiovascular, Dermatology
  Selling Product
  Carticel® (autologous cultured chondrocytes)
Epicel® (cultured epidermal autografts)

Autologous stem cell products for use in regenerative medicine: Cardiac Repair Cells (CRCs) and Vascular Repair Cells (VRCs)
  541711 - R&D; biotechnology
Contact Information
Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal